109 related articles for article (PubMed ID: 27004436)
1. Genetic mutation analysis at early stages of cell line development using next generation sequencing.
Wright C; Groot J; Swahn S; McLaughlin H; Liu M; Xu C; Sun C; Zheng E; Estes S
Biotechnol Prog; 2016 May; 32(3):813-7. PubMed ID: 27004436
[TBL] [Abstract][Full Text] [Related]
2. Enhanced CHO Clone Screening: Application of Targeted Locus Amplification and Next-Generation Sequencing Technologies for Cell Line Development.
Aeschlimann SH; Graf C; Mayilo D; Lindecker H; Urda L; Kappes N; Burr AL; Simonis M; Splinter E; van Min M; Laux H
Biotechnol J; 2019 Jul; 14(7):e1800371. PubMed ID: 30793505
[TBL] [Abstract][Full Text] [Related]
3. Sequence Variant and Posttranslational Modification Analysis During Cell Line Selection via High-Throughput Peptide Mapping.
Xu CF; Wang Y; Bryngelson P; Sosic Z; Zang L
Adv Exp Med Biol; 2019; 1140():225-236. PubMed ID: 31347050
[TBL] [Abstract][Full Text] [Related]
4. Highly sensitive detection of mutations in CHO cell recombinant DNA using multi-parallel single molecule real-time DNA sequencing.
Cartwright JF; Anderson K; Longworth J; Lobb P; James DC
Biotechnol Bioeng; 2018 Jun; 115(6):1485-1498. PubMed ID: 29427433
[TBL] [Abstract][Full Text] [Related]
5. Identifying low-level sequence variants via next generation sequencing to aid stable CHO cell line screening.
Zhang S; Bartkowiak L; Nabiswa B; Mishra P; Fann J; Ouellette D; Correia I; Regier D; Liu J
Biotechnol Prog; 2015; 31(4):1077-85. PubMed ID: 26033952
[TBL] [Abstract][Full Text] [Related]
6. Towards next generation CHO cell biology: Bioinformatics methods for RNA-Seq-based expression profiling.
Monger C; Kelly PS; Gallagher C; Clynes M; Barron N; Clarke C
Biotechnol J; 2015 Jul; 10(7):950-66. PubMed ID: 26058739
[TBL] [Abstract][Full Text] [Related]
7. Ultra-deep next generation mitochondrial genome sequencing reveals widespread heteroplasmy in Chinese hamster ovary cells.
Kelly PS; Clarke C; Costello A; Monger C; Meiller J; Dhiman H; Borth N; Betenbaugh MJ; Clynes M; Barron N
Metab Eng; 2017 May; 41():11-22. PubMed ID: 28188893
[TBL] [Abstract][Full Text] [Related]
8. Leveraging a CHO cell line toolkit to accelerate biotherapeutics into the clinic.
Wright C; Alves C; Kshirsagar R; Pieracci J; Estes S
Biotechnol Prog; 2017 Nov; 33(6):1468-1475. PubMed ID: 28842948
[TBL] [Abstract][Full Text] [Related]
9. Clinical application of amplicon-based next-generation sequencing in cancer.
Chang F; Li MM
Cancer Genet; 2013 Dec; 206(12):413-9. PubMed ID: 24332266
[TBL] [Abstract][Full Text] [Related]
10. Benchmarking and optimization of a high-throughput sequencing based method for transgene sequence variant analysis in biotherapeutic cell line development.
Groot J; Zhou Y; Marshall E; Cullen P; Carlile T; Lin D; Xu CF; Crisafulli J; Sun C; Casey F; Zhang B; Alves C
Biotechnol J; 2021 Aug; 16(8):e2000548. PubMed ID: 34018310
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of an amplicon-based next-generation sequencing panel for detection of BRCA1 and BRCA2 genetic variants.
Shin S; Hwang IS; Lee ST; Choi JR
Breast Cancer Res Treat; 2016 Aug; 158(3):433-40. PubMed ID: 27383479
[TBL] [Abstract][Full Text] [Related]
12. Mutation Detection in an Antibody-Producing Chinese Hamster Ovary Cell Line by Targeted RNA Sequencing.
Zhang S; Hughes JD; Murgolo N; Levitan D; Chen J; Liu Z; Shi S
Biomed Res Int; 2016; 2016():8356435. PubMed ID: 27088091
[TBL] [Abstract][Full Text] [Related]
13. Development and analytical validation of a 25-gene next generation sequencing panel that includes the BRCA1 and BRCA2 genes to assess hereditary cancer risk.
Judkins T; Leclair B; Bowles K; Gutin N; Trost J; McCulloch J; Bhatnagar S; Murray A; Craft J; Wardell B; Bastian M; Mitchell J; Chen J; Tran T; Williams D; Potter J; Jammulapati S; Perry M; Morris B; Roa B; Timms K
BMC Cancer; 2015 Apr; 15():215. PubMed ID: 25886519
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of an integrated clinical workflow for targeted next-generation sequencing of low-quality tumor DNA using a 51-gene enrichment panel.
Choudhary A; Mambo E; Sanford T; Boedigheimer M; Twomey B; Califano J; Hadd A; Oliner KS; Beaudenon S; Latham GJ; Adai AT
BMC Med Genomics; 2014 Nov; 7():62. PubMed ID: 25395014
[TBL] [Abstract][Full Text] [Related]
15. Integration of high-throughput analytics and cell imaging enables direct early productivity and product quality assessment during Chinese Hamster ovary cell line development for a complex multi-subunit vaccine antigen.
Li X; Zhang Y; Jing L; Fu Z; Ma O; Ganguly J; Vaidya N; Sisson R; Naginskaya J; Chinthala A; Cui M; Yamagata R; Wilson M; Sanders M; Wang Z; Lo Surdo P; Bugno M
Biotechnol Prog; 2020 Mar; 36(2):e2914. PubMed ID: 31568688
[TBL] [Abstract][Full Text] [Related]
16. Evolution of a comprehensive, orthogonal approach to sequence variant analysis for biotherapeutics.
Lin TJ; Beal KM; Brown PW; DeGruttola HS; Ly M; Wang W; Chu CH; Dufield RL; Casperson GF; Carroll JA; Friese OV; Figueroa B; Marzilli LA; Anderson K; Rouse JC
MAbs; 2019 Jan; 11(1):1-12. PubMed ID: 30303443
[TBL] [Abstract][Full Text] [Related]
17. Clinical Validation of a Next-Generation Sequencing Genomic Oncology Panel via Cross-Platform Benchmarking against Established Amplicon Sequencing Assays.
Kadri S; Long BC; Mujacic I; Zhen CJ; Wurst MN; Sharma S; McDonald N; Niu N; Benhamed S; Tuteja JH; Seiwert TY; White KP; McNerney ME; Fitzpatrick C; Wang YL; Furtado LV; Segal JP
J Mol Diagn; 2017 Jan; 19(1):43-56. PubMed ID: 27836695
[TBL] [Abstract][Full Text] [Related]
18. Early identification of unusually clustered mutations and root causes in therapeutic antibody development.
Qian Y; Chen Z; Huang X; Wang X; Xu X; Kirov S; Ludwig R; Qian NX; Ravi K; Tao L; Borys MC; Li ZJ
Biotechnol Bioeng; 2018 Sep; 115(9):2377-2382. PubMed ID: 29777592
[TBL] [Abstract][Full Text] [Related]
19. CHOgenome.org 2.0: Genome resources and website updates.
Kremkow BG; Baik JY; MacDonald ML; Lee KH
Biotechnol J; 2015 Jul; 10(7):931-8. PubMed ID: 25923813
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the Ion Torrent PGM sequencing workflow for the routine rapid detection of BRCA1 and BRCA2 germline mutations.
Zanella I; Merola F; Biasiotto G; Archetti S; Spinelli E; Di Lorenzo D
Exp Mol Pathol; 2017 Apr; 102(2):314-320. PubMed ID: 28263838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
